Publication | Closed Access

The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineImmune RegulationImmunologyAppswe/psenlde9 MiceDendritic CellsDegenerative PathologyBrain-immune InteractionNeuroprotectionNeurologyNeurodegenerationDendritic Cell BiologyNeuroimmunologyCell BiologyYoung MiceProtective MechanismsNeuroinflammation